Myriad Genetics | MYGN - Capital Ordinaire





Capital Ordinaire Changement Date
Agilent USD 282.22M 478K 2026-03
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Bio-Rad Laboratories USD 26.99M 18K 2025-12
Bruker USD 152.22M 282K 2026-03
Danaher USD 707.7M 800K 2026-03
Illumina USD 151.91M 893K 2026-03
J&J USD 2.41B 1.74M 2025-12
Mettler Toledo International USD 20.25M 179.94K 2026-03
Myriad Genetics USD 93.5M 400K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Quest Diagnostics USD 111M 1000K 2026-03
Quidel USD 67.9M 0 2025-12
Repligen USD 56.4M 74K 2026-03
Revvity USD 111.8M 1.57M 2026-03
Standard Biotools USD 386.38M 2.77M 2025-12
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Veracyte USD 79.79M 743K 2026-03
Waters USD 98.17M 89K 2026-03